We investigate empirically trade-offs between improving the cost-effectiveness of an agri-environment scheme (AES) and its distributional impacts, applying the criteria of equality (equal payments), equity (equal producer surplus), and the Rawlsian maximin criterion (here understood as...

Background Recently, the endovascular treatment (EVT) of acute ischemic stroke has made significant progress in many aspects. Intravenous thrombolysis (IVT) is usually recommended before endovascular treatment in clinical practice, but the value of the practice is controversial. The latest...

Since 2017, immune checkpoint inhibitors (ICIs) have been available for the treatment of advanced hepatocellular carcinoma (HCC) or unresectable HCC, but their adoption into national medical insurance programs is still limited. Cost-effectiveness evidence can help to inform treatment decisions....

Introduction Health economics is a thriving sub‑discipline of economics. Applied health economics research is con‑ sidered essential in the health care sector and is used extensively by public policy makers. For scholars, it is important to understand the history and status of health...

Background To estimate the long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin as an add-on therapy for type 2 diabetes patients inadequately controlled on metformin in China, to better inform healthcare decision making. Methods The Cardiff diabetes model which is a Monte...